The American Pain Society is pleased to announce the second year of the Sharon S. Keller Chronic Pain Research Program. Medical management of chronic pain produces suboptimal outcomes in many patients, characterized by inadequate pain control, unpleasant side effects, or other adverse outcomes. Therefore, non-medical alternatives are needed to enhance pain control and reduce adverse effects of treatment for chronic pain. The purpose of this grant program is to fund research projects that investigate the effectiveness of novel non-pharmacologic treatments for pain, and mechanisms underlying these treatment effects. Applications testing novel treatments or innovative applications of existing non-pharmacologic treatments are encouraged.
The Sharon S. Keller Chronic Pain Research Grants Program will award up to four grants in the amount of $35,000 to those pain research proposals that demonstrate the greatest merit and potential for success. Funds will be awarded for a twenty-four month grant period that will begin upon satisfactory execution of the grant agreement between APS and the sponsoring institution, and the receipt of IRB/IACUC approval.
Proposed research projects should investigate non-invasive interventions with favorable side effect profiles to improve chronic pain management. Projects should be designed to provide novel information regarding treatment efficacy or the mechanisms thereof. Areas of inquiry considered responsive to this grant program include, but are not limited to:
To be eligible for an APS Sharon S. Keller Chronic Pain Research Grant, applicants must be:
Sharon S. Keller Chronic Pain Research Program Review Committee
Patrick M. Dougherty, PhD, Chair
David Keller, Founder of the Sharon S. Keller Chronic Pain Research Program
Karen O. Anderson, PhD
Jin Mo Chung, PhD
Robert R Edwards, PhD
Carolyn Fairbanks, PhD
Roger Fillingim, PhD
Perry N. Fuchs, PhD
Robert Gereau, PhD
Michael Gold, PhD
Mark P. Jensen, PhD
For additional information contact APS at email@example.com or 847.375.4715.
*APS gratefully acknowledges The Sharon S. Keller Fund for Chronic Pain Management Research for the funding of this program